Description
Product details
CILINITAB M 50 Cilnidipine 10 mg & Metoprolol Succinate 50 mg Introduction to CILINITAB M 50 CILINITAB M 50 is a combination medication containing Cilnidipine (10 mg) and Metoprolol Succinate (50 mg), designed to effectively manage hypertension (high blood pressure) and related cardiovascular conditions. This dual-action therapy leverages the benefits of a calcium channel blocker (Cilnidipine) and a beta-blocker (Metoprolol Succinate) to provide comprehensive blood pressure control and enhanced cardiovascular protection. CILINITAB M 50 is ideal for patients requiring multiple mechanisms to achieve optimal blood pressure levels and improve heart health. What are Cilnidipine and Metoprolol Succinate? Overview of Cilnidipine Cilnidipine is a calcium channel blocker (CCB) that inhibits the influx of calcium ions into the smooth muscle cells of the heart and blood vessels. By blocking both L-type and N-type calcium channels, Cilnidipine effectively reduces vascular resistance, relaxes blood vessels, and lowers blood pressure. Overview of Metoprolol Succinate Metoprolol Succinate is a beta-adrenergic blocker (beta-blocker) that works by blocking beta-1 receptors in the heart. This action reduces heart rate and myocardial contractility, thereby decreasing the heart's workload and lowering blood pressure. Metoprolol is also beneficial in managing angina (chest pain) and preventing heart attacks. Benefits of CILINITAB M 50 Comprehensive Blood Pressure Control Dual Mechanism: Combining Cilnidipine and Metoprolol Succinate addresses multiple pathways involved in blood pressure regulation, providing more effective control. Reduced Vascular Resistance: Cilnidipine helps relax and widen blood vessels, while Metoprolol reduces heart rate and myocardial contractility, leading to a synergistic reduction in blood pressure. Cardiovascular Protection Heart Health: Effective blood pressure management reduces the risk of heart-related complications such as heart attacks, heart failure, and arrhythmias. Renal Protection: Cilnidipine’s action on N-type calcium channels offers additional benefits in protecting kidney function, especially in hypertensive patients with diabetes or renal impairment. Improved Quality of Life Symptom Relief: Effective blood pressure management can alleviate symptoms such as headaches, dizziness, and fatigue associated with hypertension. Long-Lasting Effect: The combination of Metoprolol Succinate and Cilnidipine provides sustained blood pressure control throughout the day. How to Use CILINITAB M 50 Dosage and Administration Recommended Dosage: The standard dose of CILINITAB M 50 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and medical condition. Administration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Guidelines for Optimal Use Consistency: For best results, take CILINITAB M 50 at the same time each day to maintain consistent blood levels. Monitoring: Regularly monitor your blood pressure and heart rate to ensure the medication is effectively controlling your condition. Follow your healthcare provider's instructions regarding blood pressure monitoring. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/cilinitab-m-50-133280
